October 21, 2014

Voyager Therapeutics Commemorates Opening of New Headquarters

Cambridge, Mass., October 21, 2014 – Voyager Therapeutics, a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS), will today celebrate the opening of its new headquarters with a ribbon cutting ceremony and open house. Voyager’s new headquarters, located at 75 Sidney Street in Cambridge, features state-of-the-art research and process development laboratories.

ribbbon-cutting

(left to right) Steven Paul, M.D., President & CEO of Voyager Therapeutics; Susan Windham-Bannister, Ph.D., President & CEO of the Massachusetts Life Sciences Center (MLSC); Mark Levin, Partner at Third Rock Ventures and Chairman of Voyager Therapeutics; Terry Flotte, M.D., Dean of the University of Massachusetts Medical School; Michael Collins, M.D., Chancellor of the University of Massachusetts Medical School; and Guangping Gao, Ph.D. Professor, Microbiology and Physiology Systems &Penelope Booth Rockwell Chair in Biomedical Research & Director, Gene Therapy Center and Vector Core Scientific Director, UMMS-China Program celebrate the opening of Voyager Therapeutics new headquarters in Cambridge, Massachusetts.

Read the press release here »

October 20, 2014

Grove Instruments Inc. Achieves Landmark Clinical Milestone

WORCESTER, MA – Grove Instruments Inc., a medical device company based in Worcester, MA, that received a $750,000 Accelerator Loan in 2011 from the Massachusetts Life Sciences Center, has achieved a landmark clinical milestone in the development of their blood glucose monitoring products.

Read the press release here »

October 20, 2014

Nihon Kohden Opens First U.S. Facility in Cambridge

Cambridge, MA — October 9, 2014 —Japan-based Nihon Kohden has announced the opening of the company’s first U.S. facility in Cambridge, MA. The facility is approximately 1,600 square feet and the Company plans to hire 5 people in the first year. Nihon Kohden is a global company with a total of 4,500 employees worldwide. Nihon Kohden Innovation Center will be the company’s first overseas research center which focuses on basic clinical research. The aim of this center is to research and develop innovative healthcare concepts with universities, institutions and hospitals throughout the United States and work together on translational research projects that will improve global medical care.

Nihon Kohden final

(left to right) Fumito Ichinose, Ph.D., M.D., Professor of Anaesthesia of the Massachusetts General Hospital; George C. Verghese, Ph.D., Henry Ellis Warren Professor of Electrical Engineering, Electrical Engineering and Computer Science of MIT; Mr. Kazuo Ogino, Chairman of Nihon Kohden Group; Pamela Norton, Vice President of Industry Relations & Programs of the MLSC; Brittany McDonough, Manager of Business Development of MOITI; and Dennis A. Benzan, Vice Mayor of Cambridge celebrate the opening of Nihon Kohden’s first U.S. facility in Cambridge, MA.

Read the press release here »

October 15, 2014

Forsyth Institute Hosts Grand Opening Ceremony for Its New Salivary Diagnostics Center

Cambridge, MA — October 15, 2014 — Today the Forsyth Institute officially opened their new Salivary Diagnostics Center in Cambridge, MA. The new facility will focus its efforts on revolutionizing medical diagnostics and replacing blood-based tests with tests that use saliva. The Massachusetts Life Sciences Center (MLSC) awarded Forsyth a $4.2 million grant in 2013 to help develop this Center.

DSCN1017

Dr. Phil Stashenko, President & CEO of the Forsyth Institute; and Susan Windham-Bannister, Ph.D., President & CEO of the Massachusetts Life Sciences Center, celebrate the grand opening of the Forsyth Institute’s new Salivary Diagnostics Center in Cambridge, Massachusetts.

Read the press release here »

October 9, 2014

ORYZON Opens U.S. Operation

ORYZON Genomics, announced today that the Company is opening a U.S. operation which will be located at 245 First Street in Cambridge, Massachusetts. After incorporation of its U.S. affiliate, Oryzon Corp, in July 2014, the U.S. arm of Oryzon Genomics is now fully launching its operations in Massachusetts. Oryzon plans to have 15-20% of its total headcount in its U.S. office in the next quarter.

DSCN0902

(left to right) Dennis Benzan, Vice Mayor of Cambridge; Angus McQuilken, Massachusetts Life Sciences Center VP for Marketing & Communications; State Representative Jay Livingstone; Lisa Hemmerle, Economic Development Director for the City of Cambridge; Carlos Buesa, President & CEO of Oryzon; Peter Abair, MassBio Director of Economic Development & Global Affairs; and Dr. Russell Greig, Member of Oryzon’s Board of Directors celebrate the opening of the company’s first U.S. office in Cambridge, Massachusetts.

Read the press release here »

October 7, 2014

inviCRO to Host Translational Imaging Symposium in Boston, MA

inviCRO, a leading provider of imaging service solutions and analysis software for drug discovery and development, will host its second Translational Imaging Symposium on Thursday October 9th at District Hall in Boston’s Innovation District.

Read the press release here »

October 2, 2014

UMass Amherst Hires Peter H. Reinhart as New Founding Director of the Institute for Applied Life Sciences

AMHERST, Mass. – The University of Massachusetts Amherst has hired veteran biopharmaceutical executive and researcher Peter H. Reinhart to be the founding director of the Institute for Applied Life Sciences (IALS). The institute was created in 2013 with $150 million in capital funding from the Massachusetts Life Sciences Center (MLSC) and additional contributions from the university to accelerate life science research and advance collaboration with industry.

Read the press release here »

September 29, 2014

Baxter to Form New Global Innovation and R&D Center Near Boston for its Biopharmaceuticals Business

DEERFIELD, Ill., September 29, 2014 – Baxter International Inc. (NYSE:BAX) today announced plans to form a new global innovation and research and development (R&D) center in Cambridge, Mass., for Baxter’s biopharmaceuticals business, which is expected to become a separate, independent global company known as Baxalta Incorporated in mid-2015.

Read the press release here »

September 29, 2014

State and Industry Officials Commend Baxter on Plans to Locate Global Innovation and R&D Center in Cambridge, Massachusetts

Cambridge, MA, September 29, 2014 –Governor Deval Patrick and Massachusetts life sciences leaders from government and industry today commended Baxter for their decision to locate 400 jobs at a new Global Innovation and R&D Center in Cambridge, Massachusetts. The new facility, eventually slated to reach 200,000 square feet, will begin operations later this year.

Read the press release here »

September 24, 2014

Harvard Medical School Opens Laboratory of Systems Pharmacology

Harvard Medical School opened its new Laboratory of Systems Pharmacology, an innovative new endeavor aimed at reinventing the fundamental science underlying drug development, located on Longwood Avenue in Boston. Harvard Medical School Dean Jeff Flier, along with Director of the Laboratory of Systems Pharmacology Peter Sorger, President & CEO of the Massachusetts Life Sciences Center Susan Windham-Bannister, Ph.D., and the Chair of the facility’s Oversight Committee, Joshua Boger were among those attending the ribbon cutting ceremony. Construction of the new research facility was funded through a $5 million grant from the Massachusetts Life Sciences Center (MLSC).

(Left to right) Co-Chair of the Advisory Council for the Harvard Program in Therapeutic Science Joshua Boger; President & CEO of the Massachusetts Life Sciences Susan Windham-Bannister; Dean of Harvard Medical School Jeffrey Flier; Executive Director of the Harvard Program in Therapeutic Science Laura Maliszewski, and Director of the Laboratory of Systems Pharmacology Peter Sorger celebrate the opening of Harvard Medical School’s new Laboratory for Systems Pharmacology.

(Left to right) Co-Chair of the Advisory Council for the Harvard Program in Therapeutic Science Joshua Boger; President & CEO of the Massachusetts Life Sciences Susan Windham-Bannister; Dean of Harvard Medical School Jeffrey Flier; Executive Director of the Harvard Program in Therapeutic Science Laura Maliszewski, and Director of the Laboratory of Systems Pharmacology Peter Sorger celebrate the opening of Harvard Medical School’s new Laboratory for Systems Pharmacology.

 

Read the press release here »

September 22, 2014

Sobi Opens North American Operations

Waltham – Monday, September 22, 2014Swedish Orphan Biovitrum AB (publ) (Sobi) today formally opened the Company’s new North American Head Office in Waltham, Massachusetts with a ribbon cutting ceremony arranged in collaboration with the Massachusetts Life Sciences Center (MLSC).

Read the press release here »

September 18, 2014

Life Sciences Delegation Meets with French Life Sciences Business Leaders to Discuss Collaboration

Massachusetts Life Sciences Center President & CEO Susan Windham-Bannister, Ph.D., today met with Life Sciences executives from the Lyon region of France to discuss what Massachusetts has to offer for growing companies in the life sciences industry. Massachusetts has become the leading destination for international life sciences companies that are looking to enter or expand their presence in the U.S. Market, including companies from France.

Read the press release here »

September 15, 2014

Governor Patrick Leads Life Sciences Innovation Partnership Forum in Denmark

As a follow-up to signing a Memorandum of Understanding (MOU) between Massachusetts and Medicon Valley in 2012, Governor Deval Patrick today spoke at a Life Sciences Innovation Partnership Forum in Copenhagen. The forum was part of the Governor’s innovation partnership mission to Denmark, the United Kingdom and France to expand opportunities between the Commonwealth and these three European countries for economic development and job creation in the innovation economy, clean tech, digital gaming, financial services, workforce training and education sectors.

Read the press release here »

September 3, 2014

MediSapiens Continues to Grow its U.S. Operations

CAMBRIDGE, MA – September 3, 2014 – MediSapiens Inc., a subsidiary of a Finland-based bioinformatics company announced today that it is ramping up its operations in the U.S. and moving to new offices in the Cambridge Innovation Center (CIC) in Kendall Square. After being incorporated in the U.S. at the end of 2013, the U.S. arm of MediSapiens is now fully launching its operations in Massachusetts, including the newly hired employees that began working this summer.

Read the press release here »

August 20, 2014

GE Healthcare Life Sciences to Create New U.S. Headquarters in Massachusetts

  • When fully operational, new facility will house  more than 500 highly skilled employees and  bring more than 220 new jobs to Massachusetts
  • Long-term investment places new US business headquarters at the heart of the most dynamic and growing life sciences, healthcare and biotech cluster in the US
  • Furthers GE Healthcare Life Sciences’ leadership in molecular and precision medicine, clinical diagnostics, manufacturing and R&D

Connect With Us

Facebook LinkedIn Twitter